APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $230,149 | -49.1% | 6,051 | +21.8% | 0.00% | -100.0% |
| Q2 2023 | $452,409 | -51.8% | 4,969 | -65.1% | 0.00% | -50.0% |
| Q1 2023 | $938,847 | +463.5% | 14,237 | +338.2% | 0.00% | – |
| Q4 2022 | $166,603 | -20.3% | 3,249 | +6.9% | 0.00% | – |
| Q3 2022 | $209,000 | +74.2% | 3,040 | +14.0% | 0.00% | – |
| Q2 2022 | $120,000 | -9.1% | 2,667 | +2.4% | 0.00% | – |
| Q1 2022 | $132,000 | -16.5% | 2,605 | -22.1% | 0.00% | – |
| Q4 2021 | $158,000 | +19.7% | 3,346 | -16.4% | 0.00% | – |
| Q3 2021 | $132,000 | -5.0% | 4,001 | +80.8% | 0.00% | – |
| Q2 2021 | $139,000 | +46.3% | 2,213 | +0.3% | 0.00% | – |
| Q1 2021 | $95,000 | -27.5% | 2,206 | -3.9% | 0.00% | – |
| Q4 2020 | $131,000 | +79.5% | 2,296 | -4.2% | 0.00% | – |
| Q3 2020 | $73,000 | -6.4% | 2,396 | 0.0% | 0.00% | – |
| Q2 2020 | $78,000 | +14.7% | 2,396 | -6.3% | 0.00% | – |
| Q1 2020 | $68,000 | – | 2,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |